ANGO vs LMT · rev $292.5M vs P/E 20, rev $75.05B
AngioDynamics Inc (ANGO) versus Lockheed Martin Corporation (LMT) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Lockheed Martin Corporation (LMT) is a aerospace & defense company listed on US. It is led by Jim Taiclet.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported LMT revenue for 2025-12-31 was $75.05B. Net income was $5.02B. Revenue was up 5.6% from 2024-12-31 to 2025-12-31. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
ANGO currently screens at market cap $378.5M. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
Not investment advice. Open the ANGO and LMT stock pages for the full models.
Not investment advice.